Company intelligence / Profile preview

Nanostics

Edmonton, Alberta, Canadananosticsdx.com ↗

Ownership: Private
Development stage: Commercial

Overview

Nanostics has developed and commercialized the ClarityDX Prostate test—a non-invasive blood-based diagnostic that uses AI to assess the risk of aggressive prostate cancer. The test was validated in a large cohort study (>3400 patients), demonstrating improved identification of aggressive disease and potential to reduce unnecessary biopsies by up to ~47%. A new randomized clinical utility trial enrolling over a thousand men at two Alberta urology centers began in April 2025. The company's technology aims to improve early detection while minimizing overtreatment.

Therapeutic areas: OncologyCardiovascularNeurology
Modalities: Device (diagnostic test)Liquid biopsy platform technologyAI-powered diagnostic test
Industry: Molecular Diagnostics

Drug pipeline

2 assets

ClarityDX Prostate

Commercial

Indications: Prostate cancer

1 more asset in the full pipeline.

Request access →

Partnerships

Alberta Precision Laboratories – sample collection support & collaboration on assay development/deployment

Beyond the preview

Go deeper on Nanostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanostics.

Explore the full profile